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Abstract
Purpose Over the past decade, nuclear medicine experts
have been seeking to minimize patient exposure to radia-
tion in myocardial perfusion scintigraphy (MPS). This
review describes the latest technological innovations in
MPS, particularly with regard to dose reduction.
Methods We searched in PubMed for original clinical
papers in English, published after 2008, using the following
research criteria: (dose) and ((reduction) or (reducing)) and
((myocardial) or (cardiac) or (heart)) and ((nuclear medi-
cine) or (nuclear imaging) or (radionuclide) or (scintigra-
phy) or (SPET) or (SPECT)). Thereafter, recent reviews on
the topic were considered and other relevant clinical papers
were added to the results.
Results Of 202 non-duplicate articles, 17 were included.
To these, another eight papers cited in recent reviews were
added. By optimizing the features of software, i.e., through
algorithms for iterative reconstruction with resolution
recovery (IRRs), and hardware, i.e., scanners and colli-
mators, and by preferring, unless otherwise indicated, the
use of stress-first imaging protocols, it has become possible
to reduce the effective dose by at least 50% in stress/rest
protocols, and by up to 89% in patients undergoing a
diagnostic stress-only study with new technology. With
today’s SPECT/CT systems, the use of a stress-first pro-
tocol can conveniently be performed, resulting in an
overall dose reduction of about 35% if two-thirds of stress-
first examinations were considered definitively normal.
Conclusion Using innovative gamma cameras, collimators
and software, as well as, unless otherwise indicated, stress-
first imaging protocols, it has become possible to reduce
significantly the effective dose in a high percentage of
patients, even when X-ray CT scanning is performed for
attenuation correction.
Keywords Myocardial perfusion imaging  SPECT  CT 
Dose reduction  Patient dose  Radiation exposure
Introduction
Radiological and nuclear medicine procedures are the
leading cause of population radiation exposure in Western
countries, and there is concern over their potential long-
term effects on patient health [1]. Even though, based on
the linear no-threshold model, radiation-induced cancer at
low doses is probabilistic, it has been demonstrated that
this risk increases after exposure to a cumulative dose of
radiation greater than 100 mSv [2], a level that can easily
be reached through repeated investigations with ionizing
radiation.
Among the various procedures involving the use of
ionizing radiation, myocardial perfusion scintigraphy
(MPS) alone is responsible for over 22% of the total
effective dose from all medical imaging procedures in the
United States [3]. Therefore, over the past decade, mini-
mization of patient exposure to radiation in nuclear cardi-
ology has become a priority not only for nuclear medicine
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physicians and health physicists, but also for technologists
who perform these scans on a daily basis [4, 5]. This
objective can be pursued by adhering to the two main
principles of radiation protection: justification of the pro-
cedure and optimization of the patient dose in relation to
the available technology.
It is to be noted that the prevalence of non-pathological
MPS findings may be as high as 35% in patients with
known coronary artery disease (CAD) and as high as 81%
in those without known CAD [6]. Therefore, conservative
strategies promoting radiation protection, such as the use of
‘‘stress-first’’ studies, should, providing there is adequate
justification, be preferred for the evaluation of patients,
since subsequent rest studies may be avoided in those with
a negative stress MPS (stress-only protocol).
The replacement (with some specific exceptions) of
201Tl-chloride with two 99mTc-labeled radiopharmaceuti-
cals (physical half-time = 6 h), namely 99mTc-sestamibi
and 99mTc-tetrofosmi, has made a major contribution to
dose optimization in MPS. More recently, the possibility of
carrying out the image acquisition with cardiac dedicated
systems rather than with general-purpose (GP) gamma
cameras has emerged, and this represents another step
forward [7].
Depending on the clinical question and the camera used,
MPS studies may require either one acquisition under
stress, or two acquisitions (one under stress and one under
rest). Accordingly, the imaging protocol may be a one-day
stress-only study (one acquisition) or either a two-day
imaging protocol or a one-day stress-first protocol (each
involving two acquisitions) [8]. Moreover, if a patient has a
large body size, this can result in a higher proportion of
emitted photons being attenuated within the patient.
Therefore, clinical MPS protocols should take into account
the patient’s weight or body mass index (BMI) [9].
The optimal amount of activity to be administered to the
single patient is determined taking all of the above vari-
ables into account. On this basis, the recommended activ-
ities, per single scan, according to the American Society of
Nuclear Cardiology (ASNC), may range from 148 MBq
(stress-only protocol, new technology, BMI = 25 kg/m2)
to 1332 MBq (second injection in a one-day stress/rest
protocol, GP gamma camera, BMI[35 kg/m2), resulting in
effective doses of between 1.0 mSv and 10.5 mSv [7].
When rest and stress studies are both performed on the
same day, the MPS dose may be as low as 4.5 mSv in
subjects with BMI = 25 kg/m2, providing the recom-
mended procedure is followed and new technologies are
employed; conversely, the patient dose can reach 13.5 mSv
when using a GP gamma camera in subjects with a BMI
[35 kg/m2.
Therefore, in this setting, the use of innovative gamma
cameras, collimators and software is crucial. By optimizing
the features of the software, i.e., through algorithms for
iterative reconstruction with resolution recovery (IRRs),
and hardware, i.e., the scanners and collimators, and by
preferring, unless otherwise indicated, the use of stress-first
imaging protocols, it has become possible to reduce the
effective dose by at least 50% in stress/rest protocols, and
by up to 89% in patients undergoing a diagnostic stress-
only study with new technology.
The development of high-efficiency cardiac dedicated
scanners equipped with cadmium–zinc–telluride (CZT)
detectors has been paralleled by the development of single
photon emission computed tomography (SPECT) systems
combined with X-ray computed tomography (CT) scan-
ners, mostly employed for attenuation correction (AC) of
the emission data. Thus, although the advanced technolo-
gies may allow reductions in patient doses, the new com-
bined scanners, due to the CT component, might actually
lead to an increase in radiation exposure [10]. The opti-
mized dose from a single CT scan for AC is in the order of
0.3–1.3 mSv [11] and, therefore, it is not negligible, when
compared with the dose from the injected radiopharma-
ceutical, especially for low-dose protocols. Whether or not
AC is actually needed is a long-debated and still unre-
solved question [12], which applies not only to MPS but
also other cardiac SPECT examinations, such as evaluation
of the sympathetic innervation [13].
The impact of stress-first/stress-only protocols and new
technologies,with andwithoutCT, on the patient dose inMPS
studies are summarized in Table 1 for normal-weight patients
and inTable 2 for obese patients. These doses are based on the
very recent ASNC imaging guidelines [7] and on epidemio-
logical data available from a large cohort study [6].
The features of the new technologies in relation to dose
optimization are described in the following paragraphs.
Dose reduction in MPS: IRR algorithms
MPS is commonly performed using GP dual-head gamma
cameras based on NaI(Tl) scintillation detectors with
photomultiplier tube array and high-resolution parallel-
hole collimators. However, limitations of these SPECT
systems—namely their low count sensitivity and poor
spatial resolution—mean that it is necessary to administer
activities in the range of 296–444 MBq for the first
radiopharmaceutical injection, and three times as much for
the second injection on the same day, and in most cases to
perform both rest and stress studies, due to the low image
quality and presence of attenuation artifacts when no form
of AC is applied (e.g., Gd-153 line source, CT or supine
and prone imaging) [14]. But this procedure may entail
injected total activities (summing both rest and stress
injected activities) of 1.184–1.776 MBq and doses of up to
13.5 mSv per patient, with acquisitions lasting
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approximately for 15 min, and overall study times of up to
4 h per patient in the case of one-day stress/rest protocols.
The IRR algorithms include resolution recovery and noise
compensation in the iterative reconstruction (IR) process,
and they make it possible to reduce the study count statistics,
without degradation of the image quality, to 25% of the
reference value of traditional IR algorithms, such as ordered-
subset expectation maximization (OSEM) [15]. The use of
CT-based AC results in a further reduction of background
noise and in an increase of uniformity also in the polar-map
representation of the left ventricular signal [16] (Figs. 1, 2).
The IRR algorithms were introduced into clinical prac-
tice primarily to reduce acquisition times, since fast
imaging provides immediate benefits in terms of patient
throughput and patient comfort. However, equivalent dose
reduction is also possible by performing standard time
acquisitions with lower injected activities.
Using the IRR algorithm AstonishTM (Philips), the
possibility of decreasing the dose to 25% of the reference
value was evaluated in the context of a two-day imaging
protocol, without AC (3 mSv for a full examination). The
authors found that decreasing radiopharmaceutical activity
to 25% of the reference value seemed practicable for nor-
mal-weight patients, while an activity reduction limited to
50% was suggested to be more appropriate for overweight
and obese patients [17]. Other studies investigated the
possibility of halving the dose to patients using the reduced
acquisition time to simulate an equivalent reduction of the
injected activity [18–20].
Bateman et al., using the AstonishTM, performed stress-
only imaging with Gd-153 for AC and half-counts, and
found this method to provide clinical results equivalent to
those of conventional stress/rest scanning without AC [21].
Marcassa et al. [22] used wide-beam reconstruction (WBR)
to compare patient effective dose in different dose
administration protocols. They found that the additional
use of an IRR algorithm made it possible to reduce patient
effective dose by 40% (from 9.5 to 5.7 mSv, p\ 0.001).
With full-time acquisitions (15 min), a 50% dose
reduction seems to be the limit for IRR algorithms. With
today’s SPECT/CT systems the use of a stress-first pro-
tocol can conveniently be performed. If two-thirds of
Table 1 Mean effective dose among different imaging protocols and SPECT technologies, with and without CT, in normal-weight patients
undergoing MPS studies with a normal rate of 66%. Data from [6] and [10]
Patient size Protocol Conventional gamma camera Newer technology New technology ? CT***
BMI = 25 kg/m2 For all patients
1-day stress/rest
















* Stress dose = 1 mSv
** Used with prone-supine or upright-supine imaging
*** CT dose of 1 mSv for stress study (total stress dose = 2 mSv)
Table 2 Mean effective dose among different imaging protocols and SPECT technologies, with and without CT, for obese patients undergoing
MPS studies with a normal rate of 66%. Data from [6] and [10]
Patient size Protocol Conventional gamma camera Newer technology New technology ? CT***
BMI[35 kg/m2 For all patients
1-day stress/rest






1 day stress/rest plus
2/3 of patients stress only*






* Stress dose = 1.5 mSv
** Used with prone-supine or upright-supine imaging
*** CT dose of 1 mSv for stress study (total stress dose = 2.5 mSv)
Clin Transl Imaging (2016) 4:491–498 493
123
patients were considered definitively normal after the
stress study, there would be no need to perform the rest
study in these patients. In such a situation, patient dose
would decrease by 76%, but the CT dose has to be added,
resulting in an overall dose reduction of about 35% (see
Tables 1, 2).
MPS dose reduction: multifocal collimators
An alternative approach, such as the IQSPECT solution
(Siemens), is to adapt a GP gamma camera to the partic-
ular application of cardiac imaging using dedicated mul-
tifocal collimators (SMARTZOOM), cardio-centric
acquisition, and an IRR algorithm optimized for myocar-
dial studies. Compared with conventional parallel colli-
mation, IQSPECT shows similar global image quality,
including resolution, but a fourfold higher sensitivity,
which allows the use of either a low-dose or a short-time
imaging protocol, or a combination of the two [23].
However, attenuation artifacts are more marked than
with parallel collimation, as well as being unpre-
dictable and position dependent; for this reason, AC is
mandatory for the IQSPECT users [24].
Very recently, Lyon et al., using IQSPECT technology,
found that one-day rest–stress gated SPECT/CT, quantita-
tive stress MPS imaging is possible with 50% of the
standard injected activity in 50% of the time with respect to
imaging using conventional gamma cameras [25].
To the best of our knowledge, no studies have been
performed with IQSPECT configuration to evaluate the
feasibility of stress-first/stress-only imaging protocol.
MPS dose reduction: CZT detectors
Technological advances have led to the development of
solid-state detectors, in particularCZT tomographs equipped
with detector geometry optimized for cardiac imaging,
which allow a greater count sensitivity (up to 7 times) with
improved spatial resolution (over 2 times) comparedwithGP
IRR IRR ACOSEM
Fig. 1 Comparison between different reconstruction protocols for
left ventricular short-axis (top) and horizontal long-axis (bottom)
images of an anthropomorphic phantom scan with in vivo reference
count statistics (Torso PhantomTM and Cardiac InsertTM, Data
Spectrum Corporation). The white arrows show an attenuation
artifact in the uncorrected images. The red arrows show a true
perfusion defect in the phantom. OSEM ordered-subset expectation
maximization, IRR iterative reconstruction with resolution recovery,





Potential reduction of patient dose
Fig. 2 Left ventricular
horizontal long-axis images of
an anthropomorphic phantom




of dose reduction. Images are
reconstructed with iterative
reconstruction algorithm with
resolution recovery plus scatter
and attenuation corrections (top)
and with filtered back projection
reconstruction (bottom)
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cameras [26]. Thanks to this sensitivity, CZT cameras pro-
vide several advantages and opportunities over GP cameras.
First, they make it possible to reduce either the amount of
injected activity or the acquisition time, or both, and thus to
optimize both. Second, due to the improved image quality of
the stress study, i.e., their fewer artifacts, stress studies have a
higher prognostic value and allow the rest study to be avoi-
ded in the presence of conclusive normal stress scans.
Two systems (Discovery NM 530c, General Electric and
D-SPECT, Spectrum Dynamics) having the same config-
uration as multiple CZT detectors, but coupled with dif-
ferent high-sensitivity collimators (multipinhole vs high-
sensitivity parallel-hole collimators, respectively) and IRR
algorithms, have been introduced on the market [27, 28]. A
comparative study, performed with an anthropomorphic
phantom mimicking the thorax of a normal adult, has
shown relatively similar physical performance of the two
CZT cameras, even though the corresponding images of the
left ventricle insert were significantly different, revealing a
smaller wall thickness with the D-SPECT than with the
Discovery NM 530c (13.6 ± 0.7 vs 19.6 ± 1.3 mm,
respectively) [29]. It is unlikely, however, that such dif-
ferences have a significant impact on diagnostic accuracy.
The study by Duvall et al. was among the first to
demonstrate that a low-dose one-day 99mTc-sestamibi
protocol (185 MBq for rest and 555 MBq for stress) with
5-min acquisition time is feasible with the Discovery
NM530c, without compromising image quality and diag-
nostic accuracy. They showed that effective doses to
patients could be reduced by 50% compared to those
associated with a conventional gamma camera [30].
Other studies have confirmed the performance of CZT
systems in halving the patient dose and, at the same time,
in reducing the acquisition time to less than 10 min (low-
dose ultrafast protocol) [31–33].
The possibility of using different patient positions, such
as prone or upright, alone or in addition to the supine
position, to reduce attenuation artifacts, due to the indi-
vidual patient’s body conformation and weight, was suc-
cessfully investigated in stress-first procedures and one-day
protocols with CZT systems (Figs. 3, 4) [34, 35].
Einstein et al. demonstrated that a stress-only imaging
protocol using an advanced CZT system and a fixed
activity could be performed in more than two-thirds of
patients with an effective dose averaging 1 mSv, in a study




Fig. 3 Comparison between stress MPS images of a 48-year-old
woman with hypertension, dyslipidemia and familiarity for CAD
acquired with two different gamma cameras. The images acquired
with a conventional dual-head GP gamma camera reveal a defect in
anterior wall due to attenuation by left breast (top), while the stress
images with a dedicated CZT gamma camera (D-SPECT) and upright
patient position show homogenous left ventricular perfusion (bottom)
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complete the full MPS examination, and that it had
excellent prognostic value [36]. One-day stress-first MPS
with 50% radiation reduction and a very low stress dose
(\2 mSv) using CZT technology and quantitative supine
and prone analysis provided a high diagnostic value, sim-
ilar to standard dose MPS [37].
However, few studies adapted the injected activities to
patient weight or BMI. In the study by Hindorf et al.,
patients received an intravenous injection of 2.5 MBq kg-1
body weight of 99mTc-tetrofosmin for the stress examina-
tion. The rest examination was performed only when the
stress images were interpreted as abnormal with an injec-
tion of 4 MBq kg-1 [33]. Very recently, Oddstig et al.
demonstrated that the linear low-dose weight-adjusted
protocol of 2.5 MBq/kg can be applied over a wide range
of body weights (51–193 kg, BMI 18–58) without loss of
counts or image quality, and resulting in a significant
reduction in radiation exposure to obese patients. In the
case of a patient weighing 120 kg, the effective dose for
the stress examination would decrease to 2.1 mSv
(300 MBq) [38].
The CZT systems are available with up to 64-slice CT
configuration (GE NM 570c). Very recently, Palyo et al.
demonstrated that an ultra-low dose (\190 MBq) in the
stress examination, even with short imaging times
(\6 min), is feasible using a hybrid CZT-SPECT/CT
camera without compromising image quality or signifi-
cantly altering quantification of myocardial perfusion or
left ventricular function [39].
However, many institutions may not have access to a
CZT-SPECT system. Although these novel scanners offer
high-quality imaging with a low radiation dose, they
remain expensive, and are used in the clinical setting only
for cardiac imaging [40].
Conclusion
Using innovative gamma cameras, collimators and soft-
ware, as well as, unless otherwise indicated, stress-first
imaging protocols, it has become possible to reduce sig-
nificantly the effective dose in a high percentage of
patients.
By combining new SPECT technologies with X-ray-
CT-based AC, MPS stress-only studies can conve-
niently be performed and likely reduce the incidence of
attenuation artifacts. Although single patients may
actually receive an increased effective dose due to
X-ray CT scanning, in the order of 1 mSv when the CT
scan is optimized for AC, application of the stress-first
protocol (SPECT ? CT) allows the reduction of the
dose over the entire population of patients undergoing
MPS evaluation, since a conclusive normal stress study
will exclude coronary artery disease and eliminate the
need to perform a rest examination. On the other hand,
an abnormal MPS will still require a rest evaluation to
differentiate ischemia from scar. To further reduce the
dose to the patients, the rest examination could be
acquired without AC. In this case, the rest images
should be compared with the corresponding non-cor-
rected stress images.
Compliance with ethics guidelines The authors declare that they
have no conflict of interest. This article does not contain any studies















Fig. 4 Comparison between stress and rest MPS images of an obese
56-year-old man (BMI 35.5 kg/m2) with suspected CAD. The stress
images acquired with a conventional dual-head GP gamma camera
show a fixed inferior wall perfusion defect due to diaphragmatic
attenuation (left), while the stress/rest images with a dedicated CZT
gamma camera (D-SPECT) and upright patient position show normal
perfusion (right)
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